Healthcare Technology Company Announces Major Platform Expansion
OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform.
Disclaimer: The information provided in this article is for informational purposes only and does not constitute financial advice or an endorsement of any particular investment strategy. The stock market carries inherent risks, and past performance is not indicative of future results.
OneMedNet Corporation (Nasdaq: ONMD), the curator of regulatory-grade Real World Data (RWD), has announced a significant milestone: a greater than five-fold expansion of its proprietary iRWD™ network and platform. This growth marks a pivotal moment for OneMedNet, showcasing its ability to scale rapidly and efficiently while meeting the increasing demand for high-quality clinical data.
Through a series of strategic network partnership agreements, including a recent deal with a nation-wide medical records custodian, OneMedNet has substantially increased its reach and capabilities. The company's expanded network now includes:
1,402 healthcare system and provider partner sites
31.0 million patients
121.4 million clinical exams
These figures represent astonishing year-to-date increases of 472% in partner sites, 170% in patients, and 122% in clinical exams since the end of 2023. Such growth underscores OneMedNet's commitment to providing comprehensive and regulatory-grade clinical data to its clients.
Vision and Execution
Aaron Green, President and CEO of OneMedNet, emphasized the importance of this expansion: “As demonstrated by this significant expansion of our network, we continue to successfully execute against the key pillars of our growth strategy. Our vision is to harness the full potential of RWD to drive innovation in healthcare. By providing our customers with comprehensive access to valuable, regulatory-grade clinical data across our growing network, we are not just furnishing more numbers — we are delivering the de-identified and hard-to-curate information needed to help foster a new era of medical excellence.” What is Real World Data? Real World Data (RWD) refers to health-related information derived from various sources, including electronic health records (EHRs), laboratory results, and medical imaging. Unlike data collected through controlled clinical trials, RWD provides insights into patient outcomes and treatment effectiveness in real-world settings. This type of data is invaluable for advancing medical research, improving patient care, and developing new drugs and medical devices. Regulatory-grade RWD meets stringent standards required by regulatory bodies, ensuring its reliability and validity for research and decision-making processes. OneMedNet’s iRWD™ platform excels in curating such data, making it an essential resource for pharmaceutical companies, medical device manufacturers, and healthcare providers seeking robust and actionable insights.
OneMedNet’s proprietary iRWD™ platform offers secure and comprehensive management of diverse clinical data types, including:
Electronic Health Records (EHRs): Detailed patient records chronicling medical history, diagnoses, treatments, and outcomes.
Laboratory Results: Critical diagnostic information that provides insights into patient health and disease progression.
Medical Imaging: Advanced imaging data that supports diagnosis, treatment planning, and monitoring.
The platform employs advanced de-identification techniques to protect patient privacy while maintaining the integrity of the data. It also features robust search and curation capabilities, enabling users to efficiently locate and utilize relevant data for their research needs. By aggregating and curating vast amounts of RWD, OneMedNet opens up numerous internal and third-party research opportunities. This capability is particularly beneficial for drug development, medical device innovation, and the advancement of diagnostic AI technologies.
Applications Across Various Medical Domains
OneMedNet’s platform provides critical data that supports research into rare diseases, which often suffer from a lack of sufficient clinical information. By offering access to comprehensive datasets, the iRWD™ platform enables researchers to identify patterns, understand disease mechanisms, and develop targeted therapies. Cancer research benefits immensely from the detailed and longitudinal data available through OneMedNet’s platform. Researchers can track patient outcomes, evaluate treatment efficacy, and explore new therapeutic approaches, ultimately contributing to better cancer care and improved survival rates. In cardiology, real-world data is essential for understanding the long-term effects of treatments and interventions. OneMedNet’s platform facilitates the collection and analysis of cardiovascular data, supporting the development of innovative treatments and improving patient outcomes. OneMedNet’s dedication to leveraging RWD for healthcare innovation is evident in its strategic partnerships and continuous platform enhancements. The company’s approach ensures that it remains at the forefront of medical research and technological advancements.
OneMedNet collaborates with leading healthcare systems, academic institutions, and industry partners to expand its network and enhance its data offerings. These partnerships are crucial for maintaining the quality and scope of the iRWD™ platform. Ongoing investments in technology and infrastructure ensure that OneMedNet’s platform remains state-of-the-art. The company continually refines its data management processes, de-identification techniques, and user interfaces to meet the evolving needs of its clients.
At the core of OneMedNet’s mission is the goal of improving patient outcomes. By providing researchers and healthcare providers with access to high-quality, regulatory-grade RWD, the company helps facilitate groundbreaking research and innovation. This, in turn, leads to the development of new treatments, improved patient care, and a better understanding of various health conditions.
OneMedNet Corporation’s impressive five-fold expansion of its iRWD™ network and platform marks a significant achievement in the field of healthcare data management. With a robust portfolio of clinical data, a commitment to innovation, and a strategic vision for the future, OneMedNet is well-positioned to drive the next wave of healthcare advancements. Investors and stakeholders should keep a close eye on OneMedNet as it continues to expand its capabilities and influence in the industry.
This month, investors should closely monitor several key factors that could influence the market. One primary area of focus is the ongoing economic data releases, including job reports, inflation rates, and consumer sentiment indices. These indicators will provide insights into the health of the economy and potential monetary policy adjustments by the Federal Reserve. Additionally, any developments in geopolitical tensions or significant legislative changes, particularly those impacting sectors like technology and healthcare, could also sway market sentiments. Investors should stay updated on corporate earnings reports, as companies’ performance can significantly impact stock prices and investment strategies.
We discovered a few growth stocks that are garnering considerable attention this year. OneMedNet Corporation (Nasdaq: ONMD) stands out after reporting a greater than five-fold expansion of its iRWD™ network and platform. This significant growth positions OneMedNet as a formidable player in the healthcare data management space, with its proprietary platform offering valuable regulatory-grade Real World Data (RWD). The company’s focus on expanding partnerships and enhancing its data curation capabilities makes it a compelling option for investors seeking exposure to the burgeoning field of health data analytics. Another healthcare technology stock to watch is Teladoc Health (NYSE: TDOC), a leader in the telemedicine industry. With the increasing adoption of virtual healthcare services, Teladoc’s comprehensive telehealth solutions continue to attract a growing user base. The company’s efforts to integrate advanced technologies, such as artificial intelligence, into its service offerings further enhance its growth prospects. Additionally, investors should keep an eye on companies like Cerner Corporation (NASDAQ: CERN), which specializes in health information technology solutions, and has been expanding its footprint through strategic partnerships and acquisitions.
The healthcare technology sector presents numerous opportunities for growth, driven by advancements in digital health, patient data management, and telemedicine. As the demand for innovative healthcare solutions continues to rise, companies that can effectively leverage technology to improve patient outcomes and streamline operations are likely to see sustained growth. Investors should conduct thorough research and consider diversifying their portfolios to include promising healthcare technology stocks that align with these trends.
Disclaimer: The information provided in this article is for informational purposes only and does not constitute financial advice or an endorsement of any particular investment strategy. The stock market carries inherent risks, and past performance is not indicative of future results. Before making any investment decisions, we strongly recommend consulting with a qualified financial advisor who can tailor advice to your specific circumstances. We do not guarantee the accuracy or completeness of the data presented, and we are not liable for any losses or damages arising from the use of this information. Investing in stocks involves risks, including the potential loss of principal. Always conduct your own research and due diligence before investing in any securities.
As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.